Literature DB >> 26249284

Brain disease model of addiction: why is it so controversial?

Nora D Volkow1, George Koob2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26249284      PMCID： PMC4556943          DOI： 10.1016/S2215-0366(15)00236-9

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  7 in total

Review 1.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

2.  The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises?

Authors:  Wayne Hall; Adrian Carter; Cynthia Forlini
Journal:  Lancet Psychiatry       Date:  2015-01-08       Impact factor: 27.083

3.  The affordable care act and treatment for "substance use disorders:" implications of ending segregated behavioral healthcare.

Authors:  A Thomas McLellan; Abigail Mason Woodworth
Journal:  J Subst Abuse Treat       Date:  2014-02-25

4.  Cognitive related electrophysiological changes induced by non-invasive cortical electrical stimulation in crack-cocaine addiction.

Authors:  Catarine Lima Conti; Janine Andrade Moscon; Felipe Fregni; Michael Andreas Nitsche; Ester Miyuki Nakamura-Palacios
Journal:  Int J Neuropsychopharmacol       Date:  2014-04-28       Impact factor: 5.176

5.  Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial.

Authors:  Limor Dinur-Klein; Pinhas Dannon; Aviad Hadar; Oded Rosenberg; Yiftach Roth; Moshe Kotler; Abraham Zangen
Journal:  Biol Psychiatry       Date:  2014-06-05       Impact factor: 13.382

6.  The effects of federal parity on substance use disorder treatment.

Authors:  Susan H Busch; Andrew J Epstein; Michael O Harhay; David A Fiellin; Hyong Un; Deane Leader; Colleen L Barry
Journal:  Am J Manag Care       Date:  2014       Impact factor: 2.229

Review 7.  Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.

Authors:  George F Koob; Eric P Zorrilla
Journal:  Curr Opin Investig Drugs       Date:  2010-01
  7 in total
  30 in total

Review 1.  A review of the effects of nicotine on social functioning.

Authors:  Lea M Martin; Michael A Sayette
Journal:  Exp Clin Psychopharmacol       Date:  2018-06-28       Impact factor: 3.157

2.  News Feature: Is video game addiction really an addiction?

Authors:  Mark Zastrow
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-25       Impact factor: 11.205

3.  Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).

Authors:  Kenneth Blum; Marcelo Febo; Lyle Fried; Mona Li; Kristina Dushaj; Eric R Braverman; Thomas McLaughlin; Bruce Steinberg; Rajendra D Badgaiyan
Journal:  Subst Use Misuse       Date:  2016-12-29       Impact factor: 2.164

Review 4.  A Neurobehavioral Approach to Addiction: Implications for the Opioid Epidemic and the Psychology of Addiction.

Authors:  Antoine Bechara; Kent C Berridge; Warren K Bickel; Jose A Morón; Sidney B Williams; Jeffrey S Stein
Journal:  Psychol Sci Public Interest       Date:  2019-10

Review 5.  Insights from Preclinical Choice Models on Treating Drug Addiction.

Authors:  Matthew L Banks; S Stevens Negus
Journal:  Trends Pharmacol Sci       Date:  2016-12-02       Impact factor: 14.819

Review 6.  Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research.

Authors:  John F Kelly
Journal:  Addiction       Date:  2016-10-08       Impact factor: 6.526

Review 7.  The case for investigating social context in laboratory studies of smoking.

Authors:  John D Dimoff; Michael A Sayette
Journal:  Addiction       Date:  2016-08-08       Impact factor: 6.526

Review 8.  Neurobiologic Advances from the Brain Disease Model of Addiction.

Authors:  Nora D Volkow; George F Koob; A Thomas McLellan
Journal:  N Engl J Med       Date:  2016-01-28       Impact factor: 91.245

9.  The benefits of genetic addiction risk score (GARS™) and pro-dopamine regulation in combating suicide in the American Indian population.

Authors:  Kenneth Blum; David Siwicki; David Baron; Edward J Modestino; Rajendra D Badgaiyan
Journal:  J Syst Integr Neurosci       Date:  2018-09-14

10.  Dopamine manipulations drive changes in information sampling in healthy volunteers.

Authors:  Raquel Vicario-Feliciano; Rebekah L Wigton; Thomas P White; Sukhi S Shergill; Bruno B Averbeck
Journal:  J Psychopharmacol       Date:  2019-01-15       Impact factor: 4.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.